TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Immunbutiken AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
213
|
210
|
312 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-6
|
4
|
22 |
| EBITDA |
-6
|
4
|
22 |
| Total assets |
60
|
63
|
85 |
| Current assets |
60
|
63
|
85 |
| Current liabilities |
38
|
25
|
27 |
| Equity capital |
20
|
34
|
51 |
| - share capital |
9
|
9
|
10 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
33.3%
|
54.0%
|
60.0% |
| Turnover per employee |
106
|
105
|
156 |
| Profit as a percentage of turnover |
-2.8%
|
1.9%
|
7.1% |
| Return on assets (ROA) |
-10.0%
|
6.3%
|
25.9% |
| Current ratio |
157.9%
|
252.0%
|
314.8% |
| Return on equity (ROE) |
-30.0%
|
11.8%
|
43.1% |
| Change turnover |
3
|
-77
|
47 |
| Change turnover % |
1%
|
-27%
|
18% |
| Chg. No. of employees |
0
|
0
|
-1 |
| Chg. No. of employees % |
0%
|
0%
|
-33% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.